Modified oncolytic vaccinia virus

作者: Vincenzo Cerullo , Akseli Hemminki , Eerika Karli , Markus Vähä-Koskela , Julia Diaconu

DOI:

关键词: VirologyThymidine Kinase GeneGeneAdjuvantOncolytic virusVirusVaccinia growth factorBiologyCancerVaccinia

摘要: The invention relates to modified oncolytic vaccinia virus vectors and their uses in cancer therapy. comprise inactivating mutations the thymidine kinase gene growth factor addition genes encoding marker or adjuvant proteins. A production method for inventive construct is also disclosed. are useful systemic sequential therapeutic use cancer.

参考文章(68)
Lucas J. Thompson, Ganesh A. Kolumam, Sunil Thomas, Kaja Murali-Krishna, Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation. Journal of Immunology. ,vol. 177, pp. 1746- 1754 ,(2006) , 10.4049/JIMMUNOL.177.3.1746
Steven K. Libutti, Bernard Moss, H. Richard Alexander, Jerrold M. Ward, Yun Hu, J. Andrea McCart, David L. Bartlett, John Lee, Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes. Cancer Research. ,vol. 61, pp. 8751- 8757 ,(2001)
Ananda W. Goldrath, Michael J. Bevan, Stefan Martin, Peter Brossart, Eric A. Butz, Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. Journal of Immunology. ,vol. 158, pp. 3270- 3276 ,(1997)